"The most successful strategies to date are those aimed at the epidermal growth factor receptor (EGFR), which is found to be upregulated in 40%-80% of NSCLC."
http://www.ncbi.nlm.nih.gov/pubmed/21116327
Biologics. 2010 Nov 9;4:289-98.
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.
Boland W, Bebb G.
Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada.
No comments:
Post a Comment